Patent: 8,404,230
✉ Email this page to a colleague
Summary for Patent: 8,404,230
Title: | Therapeutic combination comprising a pulmonary surfactant and antioxidant enzymes |
Abstract: | Administration of an exogenous pulmonary surfactant in combination with antioxidant enzymes is effective for the prevention of bronchopulmonary dysplasia (BPD) and decreases the markers of pulmonary oxidative stress. |
Inventor(s): | Dani; Carlo (Parma, IT) |
Assignee: | Chiesi Farmaceutici S.p.A. (Parma, IT) |
Application Number: | 13/402,148 |
Patent Claims: | see list of patent claims |
Details for Patent 8,404,230
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Abbvie Inc. | SURVANTA | beractant | Suspension | 020032 | 07/01/1991 | ⤷ Try a Trial | 2029-09-08 |
Ony Biotech Inc. | INFASURF | calfactant | Suspension | 020521 | 07/01/1998 | ⤷ Try a Trial | 2029-09-08 |
Ony Biotech Inc. | INFASURF | calfactant | Suspension | 020521 | 12/12/2002 | ⤷ Try a Trial | 2029-09-08 |
Ony Biotech Inc. | INFASURF | calfactant | Suspension | 020521 | ⤷ Try a Trial | 2029-09-08 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |